Toggle navigation
Home
Search
Services
Blog
Contact
About
Development-266030017-266030017
Acambis, Inc., Cambridge, MA, United States
Search grants from Acambis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Herpes simplex virus-1 evasion of CD1d antigen presentation pathway
Secondary analysis of Human Mammary Tumor Virus (HMTV) in breast cancer.
Social Identity, Social Justice, and Intellectual Property
Structural Studies of Methyl Cycle Enzymes
Cell Cycle Checkpoint Regulation and Cancer
Recently added grants:
Pharmacokinetic assessment of peptide-based therapy HV-3 for the treatment of Huntington's disease
Culturally relevant contributors to cognitive and MRI changes in older Latinos
Ultralong-term single-molecule imaging of amyloid precursor protein (APP) processing in Alzheimer's disease
Molecular Mechanisms of Viral Entry by Membrane Fusion
Quorum Sensing Regulation of EHEC Virulence Genes
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030017-006
Application #
7329521
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Acambis, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 2006
N01 AI
Development-266030017-266030017
/ Acambis, Inc.
NIH 2004
N01 AI
Development-266030017
/ Acambis, Inc.
NIH 2003
N01 AI
Development-266030017
/ Acambis, Inc.
Comments
Be the first to comment on this grant